Cite
HARVARD Citation
Abid, M. et al. (2018). Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL. Leukemia research reports. pp. 5-8. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abid, M. et al. (2018). Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL. Leukemia research reports. pp. 5-8. [Online].